-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Panacea Life Sciences Holdings, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2020 to Q1 2024.
- Panacea Life Sciences Holdings, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$389K, a 22.5% increase year-over-year.
- Panacea Life Sciences Holdings, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was -$2.36M, a 17.5% increase year-over-year.
- Panacea Life Sciences Holdings, Inc. annual Nonoperating Income (Expense) for 2023 was -$2.47M, a 29.3% increase from 2022.
- Panacea Life Sciences Holdings, Inc. annual Nonoperating Income (Expense) for 2022 was -$3.49M, a 402% decline from 2021.
- Panacea Life Sciences Holdings, Inc. annual Nonoperating Income (Expense) for 2021 was $1.15M, a 4339% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)